Dassault Systèmes SE (DSYA.F)
- Business Wire
Lexicon Pharmaceuticals Selects Medidata to Help Advance First Non-Opioid Drug for Neuropathic Pain in Over Two Decades
NEW YORK, May 29, 2024--Medidata, a Dassault Systèmes brand and leading provider of clinical trial solutions to the life sciences industry, announced today that it has been selected by Lexicon Pharmaceuticals, Inc. to help advance PROGRESS, a Phase 2b study of LX9211 in diabetic peripheral neuropathic pain (DPNP), with the potential for LX9211 to become the first new, non-opioid drug approved for neuropathic pain in over two decades. Medidata will enable Lexicon to accelerate patient enrollment
- Business Wire
Medidata Selected by Worldwide Clinical Trials to Accelerate Trials and Transform Patient Experience
NEW YORK, May 14, 2024--Medidata, a Dassault Systèmes brand and leading provider of clinical trial solutions to the life sciences industry, today announced an expansion of its relationship with Worldwide Clinical Trials ("Worldwide"), a full-service global contract research organization (CRO). The agreement will facilitate data-driven decision-making across Worldwide’s entire clinical operations with the implementation of Medidata AI and enable Worldwide to support customers by reducing trial ti
- GlobeNewswire
Dassault Systèmes: JLR and Dassault Systèmes Extend Partnership, Deploying the 3DEXPERIENCE Platform for All Vehicle Programs Worldwide
Press ReleaseVELIZY-VILLACOUBLAY, France — May 14, 2024 JLR and Dassault Systèmes Extend Partnership, Deploying the 3DEXPERIENCE Platform for All Vehicle Programs Worldwide Five-year partnership marks the next phase of their long-standing collaboration to drive the automaker’s transformation for a good and responsible businessMore than 18,000 users globally will utilize virtual twins to increase the efficiency of vehicle engineering and digital manufacturing, save time, and reduce waste and cost
